Literature DB >> 11139198

Apoptosis in T-lymphocyte subsets in human immunodeficiency virus-infected children measured immediately ex vivo and following in vitro activation.

T Niehues1, T W McCloskey, J Ndagijimana, G Horneff, V Wahn, S Pahwa.   

Abstract

Phosphatidylserine molecules are translocated to the outer plasma membrane of lymphocytes undergoing apoptosis and can be detected by the binding of fluorochrome-conjugated annexin V. Using the annexin V assay, we examined CD4 and CD8 T cells from human immunodeficiency virus (HIV)-infected children for apoptosis upon isolation or following in vitro culture. Immediate ex vivo analysis or overnight culture showed significantly higher levels of apoptosis in CD8 cells than in CD4 cells. Following culture with the activating stimulus phytohemagglutinin or anti-CD3 monoclonal antibody, we observed an increase in the percentage of apoptotic CD4 cells, whereas there was no change in the rate of CD8 cell death. These results demonstrate that in HIV-infected children, CD8 apoptosis may occur at a greater rate than CD4 apoptosis in vivo; greater CD4 depletion may be observed due to more efficient mechanisms for peripheral lymphocyte replacement in the CD8 compartment. Furthermore, our data suggest that CD8 lymphocytes may be maximally activated in vivo, a condition which may lead to the exhaustion of CD8-mediated immunity. These findings clarify the differences between the CD4 and CD8 apoptotic responses to HIV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139198      PMCID: PMC96013          DOI: 10.1128/CDLI.8.1.74-78.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy.

Authors:  C L Mackall; T A Fleisher; M R Brown; M P Andrich; C C Chen; I M Feuerstein; I T Magrath; L H Wexler; D S Dimitrov; R E Gress
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

2.  Dual role of HIV Tat in regulation of apoptosis in T cells.

Authors:  T W McCloskey; M Ott; E Tribble; S A Khan; S Teichberg; M O Paul; S Pahwa; E Verdin; N Chirmule
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

3.  T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover.

Authors:  K C Wolthers; G Bea; A Wisman; S A Otto; A M de Roda Husman; N Schaft; F de Wolf; J Goudsmit; R A Coutinho; A G van der Zee; L Meyaard; F Miedema
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

Review 4.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

Authors:  M van Engeland; L J Nieland; F C Ramaekers; B Schutte; C P Reutelingsperger
Journal:  Cytometry       Date:  1998-01-01

5.  Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection.

Authors:  M F Cotton; D N Ikle; E L Rapaport; S Marschner; P O Tseng; R Kurrle; T H Finkel
Journal:  Pediatr Res       Date:  1997-11       Impact factor: 3.756

6.  Costimulatory pathways mediate monocyte-dependent lymphocyte apoptosis in HIV.

Authors:  D E Lewis; D S Ng Tang; X Wang; C Kozinetz
Journal:  Clin Immunol       Date:  1999-03       Impact factor: 3.969

7.  Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes.

Authors:  G Herbein; C Van Lint; J L Lovett; E Verdin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis.

Authors:  R B Effros; R Allsopp; C P Chiu; M A Hausner; K Hirji; L Wang; C B Harley; B Villeponteau; M D West; J V Giorgi
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

9.  Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.

Authors:  P D Katsikis; M E Garcia-Ojeda; J F Torres-Roca; I M Tijoe; C A Smith; L A Herzenberg; L A Herzenberg
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins.

Authors:  L D Palmer; N Weng; B L Levine; C H June; H C Lane; R J Hodes
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  5 in total

1.  polyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiency.

Authors:  Elke Lainka; Michael S Hershfield; Ines Santisteban; Pawan Bali; Annette Seibt; Jennifer Neubert; Wilhelm Friedrich; Tim Niehues
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis.

Authors:  Sabine Knipp; Oliver Feyen; Jennnifer Ndagijimana; Tim Niehues
Journal:  Rheumatol Int       Date:  2002-12-04       Impact factor: 2.631

3.  Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children.

Authors:  Monica Kharbanda; Thomas W McCloskey; Rajendra Pahwa; Mei Sun; Savita Pahwa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

4.  A single intravenous dose of prednisolone induces phosphatidylserine externalization, loss of surface marker expression and a 24-h net increase in human peripheral blood lymphocytes ex vivo.

Authors:  Martin Jetzek-Zader; Sonja Gudowius; Oliver Feyen; Markus Stevens; Peter Lipfert; Tim Niehues
Journal:  Rheumatol Int       Date:  2007-03-01       Impact factor: 3.580

Review 5.  Dual Antiretroviral Therapy-All Quiet Beneath the Surface?

Authors:  Berend J van Welzen; Patrick G A Oomen; Andy I M Hoepelman
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.